Clearstead Advisors’s Gabelli Healthcare & Wellness Trust GRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-104
Closed -$1.05K 2795
2025
Q1
$1.05K Buy
104
+1
+1% +$10 ﹤0.01% 1984
2024
Q4
$990 Buy
103
+2
+2% +$21 ﹤0.01% 1922
2024
Q3
$1.11K Buy
101
+1
+1% +$11 ﹤0.01% 1903
2024
Q2
$956 Buy
100
+2
+2% +$19 ﹤0.01% 1899
2024
Q1
$956 Buy
98
+1
+1% +$10 ﹤0.01% 1409
2023
Q4
$903 Sell
97
-93
-49% -$799 ﹤0.01% 1413
2023
Q3
$1.63K Buy
190
+96
+102% +$916 ﹤0.01% 1427
2023
Q2
$933 Buy
94
+2
+2% +$20 ﹤0.01% 1257
2023
Q1
$931 Buy
92
+1
+1% +$10 ﹤0.01% 1251
2022
Q4
$934 Buy
91
+1
+1% +$10 ﹤0.01% 1179
2022
Q3
$1K Buy
90
+2
+2% +$22 ﹤0.01% 1151
2022
Q2
$1K Buy
88
+1
+1% +$12 ﹤0.01% 1184
2022
Q1
$1K Buy
87
+3
+4% +$38 ﹤0.01% 1292
2021
Q4
$1K Buy
84
+1
+1% +$13 ﹤0.01% 1181
2021
Q3
$1K Buy
83
+1
+1% +$14 ﹤0.01% 1209
2021
Q2
$1K Buy
82
+1
+1% +$13 ﹤0.01% 1153
2021
Q1
$1K Buy
+81
New +$994 ﹤0.01% 1029

Other funds holding GRX

Clearstead Advisors's GRX Position: Q2 2025 in Review

Clearstead Advisors sold out of Gabelli Healthcare & Wellness Trust (GRX) in Q2 2025, closing a stake of 104 shares — an estimated $1.05K sold.

Clearstead Advisors first reported a position in GRX in Q1 2021 and held it in 17 quarters. The position peaked at $1.63K in Q3 2023. 58 funds tracked by Wall St. Rank hold GRX as of Q2 2025.

  • Clearstead Advisors reported no remaining Gabelli Healthcare & Wellness Trust position as of Q2 2025 after selling out during the quarter.
  • Clearstead Advisors sold 104 Gabelli Healthcare & Wellness Trust shares in Q2 2025, an estimated $1.05K.
  • Clearstead Advisors first reported a position in Gabelli Healthcare & Wellness Trust in Q1 2021 and held it in 17 quarters.
  • Clearstead Advisors's Gabelli Healthcare & Wellness Trust position peaked at $1.63K in Q3 2023.
  • 58 funds tracked by Wall St. Rank held Gabelli Healthcare & Wellness Trust as of Q2 2025.

Based on Clearstead Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.